FI810007A7 - Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille. - Google Patents

Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille. Download PDF

Info

Publication number
FI810007A7
FI810007A7 FI810007A FI810007A FI810007A7 FI 810007 A7 FI810007 A7 FI 810007A7 FI 810007 A FI810007 A FI 810007A FI 810007 A FI810007 A FI 810007A FI 810007 A7 FI810007 A7 FI 810007A7
Authority
FI
Finland
Prior art keywords
cancer cells
human cancer
detection
antibodies specific
nuclear antigens
Prior art date
Application number
FI810007A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI810007L (fi
Inventor
Harris Busch
Rose K Busch
Ferenc Gyorkey
Phyllis Gyorkey
Frances M Davis
Karel Smetana
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of FI810007L publication Critical patent/FI810007L/fi
Publication of FI810007A7 publication Critical patent/FI810007A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
FI810007A 1980-01-04 1981-01-02 Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille. FI810007A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000343088A CA1157373A (en) 1980-01-04 1980-01-04 Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s)

Publications (2)

Publication Number Publication Date
FI810007L FI810007L (fi) 1981-07-05
FI810007A7 true FI810007A7 (fi) 1981-07-05

Family

ID=4115973

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810007A FI810007A7 (fi) 1980-01-04 1981-01-02 Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille.

Country Status (27)

Country Link
JP (1) JPS56101553A (cg-RX-API-DMAC7.html)
KR (1) KR850001770B1 (cg-RX-API-DMAC7.html)
AR (1) AR232046A1 (cg-RX-API-DMAC7.html)
AT (1) AT373397B (cg-RX-API-DMAC7.html)
AU (1) AU535024B2 (cg-RX-API-DMAC7.html)
BE (1) BE886935A (cg-RX-API-DMAC7.html)
CA (1) CA1157373A (cg-RX-API-DMAC7.html)
CH (1) CH659328A5 (cg-RX-API-DMAC7.html)
DE (1) DE3047654A1 (cg-RX-API-DMAC7.html)
DK (1) DK554980A (cg-RX-API-DMAC7.html)
ES (2) ES498305A0 (cg-RX-API-DMAC7.html)
FI (1) FI810007A7 (cg-RX-API-DMAC7.html)
FR (1) FR2484650B1 (cg-RX-API-DMAC7.html)
GB (1) GB2067286B (cg-RX-API-DMAC7.html)
GR (1) GR72850B (cg-RX-API-DMAC7.html)
IE (1) IE50760B1 (cg-RX-API-DMAC7.html)
IL (1) IL61641A (cg-RX-API-DMAC7.html)
IT (1) IT1172216B (cg-RX-API-DMAC7.html)
LU (1) LU83015A1 (cg-RX-API-DMAC7.html)
NL (1) NL8007128A (cg-RX-API-DMAC7.html)
NO (2) NO803910L (cg-RX-API-DMAC7.html)
NZ (1) NZ195756A (cg-RX-API-DMAC7.html)
OA (1) OA06713A (cg-RX-API-DMAC7.html)
PH (5) PH18765A (cg-RX-API-DMAC7.html)
PT (1) PT72301B (cg-RX-API-DMAC7.html)
SE (1) SE450665B (cg-RX-API-DMAC7.html)
ZA (1) ZA807754B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
US4871661A (en) * 1983-11-23 1989-10-03 The Ohio State University Research Foundation Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment
US4746539A (en) * 1983-11-23 1988-05-24 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
EP0145373B1 (en) * 1983-11-23 1992-03-25 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4645737A (en) * 1984-03-05 1987-02-24 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-treponemal antibodies
US4607008A (en) * 1984-03-05 1986-08-19 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies
EP0162977B1 (en) * 1984-05-02 1992-05-20 University Research Corporation Enzyme immunoassay for cancer procoagulant
US4616658A (en) * 1985-02-27 1986-10-14 William Shell Non-radioactively labeled microspheres and use of same to measure blood flow
US4798719A (en) * 1986-09-11 1989-01-17 University Of Pittsburgh Method for selection of antigens suitable as in vivo targets for antibodies
US5019368A (en) * 1989-02-23 1991-05-28 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
CA2023030A1 (en) * 1990-07-13 1992-01-14 Robert R. Guerrero In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals

Also Published As

Publication number Publication date
DE3047654C2 (cg-RX-API-DMAC7.html) 1990-12-20
PH18637A (en) 1985-08-23
GB2067286B (en) 1984-01-04
FI810007L (fi) 1981-07-05
DK554980A (da) 1981-07-05
KR850001770B1 (ko) 1985-12-18
IL61641A0 (en) 1981-01-30
FR2484650B1 (fr) 1985-06-21
LU83015A1 (fr) 1981-06-04
PH18129A (en) 1985-03-22
AT373397B (de) 1984-01-10
SE450665B (sv) 1987-07-13
IE50760B1 (en) 1986-07-09
NO850005L (no) 1981-07-06
PH18624A (en) 1985-08-21
NL8007128A (nl) 1981-08-03
DE3047654A1 (de) 1981-09-10
NZ195756A (en) 1983-11-18
ZA807754B (en) 1982-02-24
BE886935A (fr) 1981-04-16
AU535024B2 (en) 1984-03-01
IT8167001A0 (it) 1981-01-05
FR2484650A1 (fr) 1981-12-18
GB2067286A (en) 1981-07-22
CH659328A5 (de) 1987-01-15
PH18765A (en) 1985-09-20
AR232046A1 (es) 1985-04-30
IL61641A (en) 1984-03-30
SE8100011L (sv) 1981-07-05
ATA1081A (de) 1983-05-15
AU6507080A (en) 1981-07-09
CA1157373A (en) 1983-11-22
PT72301B (en) 1981-11-10
IT1172216B (it) 1987-06-18
ES8206855A1 (es) 1982-08-01
IE802533L (en) 1981-07-04
KR830003898A (ko) 1983-06-30
ES8307377A1 (es) 1983-06-16
NO803910L (no) 1981-07-06
PT72301A (en) 1981-01-01
PH18636A (en) 1985-08-23
OA06713A (fr) 1982-06-30
ES509239A0 (es) 1983-06-16
JPS56101553A (en) 1981-08-14
ES498305A0 (es) 1982-08-01
GR72850B (cg-RX-API-DMAC7.html) 1983-12-07

Similar Documents

Publication Publication Date Title
IT1119257B (it) Procedimento e reagente per raggi immunologici
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
DE3382283D1 (de) Monoklonale antikoerper spezifisch gegen das karzinoembryonische antigen.
JPS5786051A (en) Determination of antigen employing two or more monochronal antibodies
FI864037A7 (fi) Monoklonaaliset vasta-aineet ihmisen rintasyöpää vastaan.
FI893300A7 (fi) Ihmisen B-solun pinta-antigeenille spesifinen kimeerinen vasta-aine
IT1153857B (it) Rivelazione di tumori con anticorpi monoclonali radiomarcati
AT372427B (de) Zellstoffwaschvorrichtung
DK373182A (da) Antigenbestemmelse
DK98187D0 (da) Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma
IT7920592A0 (it) Determinazione di antigeni oppure di anticorpi.
AU1172983A (en) Antibodies and antigens for malignant cell detection
DE3177276D1 (de) Monoklonale antikoerper.
AU535024B2 (en) Detecting cancer with antibodies
RO92427A (ro) Anticorpi monoclonali pentru detectarea celulelor maligne si procedeude obtinere a acestora
NO153910C (no) Direkte agglutineringsproeve for paavisning av antigener i kroppsvaesker.
IT7848508A0 (it) Antigeni e anticorpi della teofillina
BR8103923A (pt) Moderador sanitario
BE854269A (fr) Antigene contre les tumeurs et son procede de preparation
EP0277970A4 (en) Monoclonal antibody against ovarian cancer cells (ovb-3).
IT1153188B (it) Procedimento immunoenzimatico per il rilevamento di anticorpi antinucleari
DE3066975D1 (en) Propranolol antigen conjugates and antibodies and method of using them
EP0060871A4 (en) MONOCLONAL ANTIBODIES, SPECIFIC TO HUMAN HOPEOPIETIC CELL SURFACE GLYCOPROTEINS.
GB2097425B (en) Monoclonal antibody for b type blood cells
ATE16200T1 (de) Monoklonale antikoerper, spezifisch zu menschlichen hematopoietischen zelloberflaechenglycoproteinen.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BAYLOR COLLEGE OF MEDICINE